西门子受惠会计受益 上季季绩胜预期
西门子截至6月底第三财季调整後的工业业部EBITA增长8%至至17.9亿欧元,优於市场预期的11.7亿欧元,因虽然订单及收入均出现下跌,但季内录得会计收益,当中有持有的美国工业软件公司Bentley Systems的估值增加2.11亿欧元。
西门子此前曾警告,由於疫情爆发将对第三季业绩产生重大影响,故放弃全年业绩指引,并宣布加快现有的削减成本计划。
西门子第三季盈利减少53%至5.35亿欧元,远胜於市场预期的5,100万欧元,收入下降5%至134.9亿欧元,同样优於预期。
西门子仍预计疫情将严重影响第四季度的业务,相信全年可比收入会有所下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.